Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Top Stories

Recent articles that are of ongoing interest...

China Proposes Rules for IPOs on New Shanghai Hi-Tech Stock Exchange

FibroGen/AstraZeneca Novel Anemia Drug Approved in China -- Before US/EU Approvals

Shanghai Junshi Bioscience to Raise $414 Million in Hong Kong IPO

CStone Pharma Files for Hong Kong IPO to Support its Oncology Portfolio

Shanghai Stock Exchange to Set Up New Board for Innovative Science and Tech Companies

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 5-6, 2019

Shanghai , China
March 26-28, 2019